DELTEX
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90563497
- Registration number
- 7995024
- Mark type
- Stylized text
- Filed
- 05 Mar 2021
- Published for opposition
- 09 Nov 2021
- Registered
- 21 Oct 2025
- Attorney of record
- Mark Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer
- Class 042 — Scientific and technological services: Medical research and development; Research and development of pharmaceuticals; Research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Molecular, cellular, and genetic research and development; Development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders
- Class 044 — Medical, beauty and agricultural services: Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment
Owner
- In8bio, Inc., New York, NY, US
- In8bio, Inc., New York, NY, US
- In8bio, Inc., New York, NY, US
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Oct 2025 — ASSIGNED TO LIE
- 25 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 25 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Mar 2025 — NON-FINAL ACTION E-MAILED
- 25 Mar 2025 — SU - NON-FINAL ACTION - WRITTEN
- 18 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jan 2025 — USE AMENDMENT FILED